News | May 12, 2026
CORONA Remedies FY26 revenue rises 17.3% to Rs. 1,403 crore
The company’s PAT rose 43.7% year-on-year to Rs. 45.3 crore in Q4FY26 from Rs. 31.5 crore
The company’s PAT rose 43.7% year-on-year to Rs. 45.3 crore in Q4FY26 from Rs. 31.5 crore
This certification paves the way for CORONA's entry into five EAEU member nations- Russia, Kyrgyzstan, Armenia, Belarus, and Kazakhstan-under a B2B business model
The company’s consolidated revenue from operations rose to Rs. 361.13 crore in Q2 FY26 and Rs. 707.67 crore for the first half
Subscribe To Our Newsletter & Stay Updated
